Ftse Mib
34.943,77
0,01%
DAX
20.263,31
-0,43%
S&P 500
5.896,57
-0,21%
NASDAQ
19.427,22
-0,32%
Bitcoin
94.991,05
-1,99%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relay Therapeutics Inc (RLAY) Relay Therapeutics Inc (RLAY) Notizie

Relay Therapeutics Inc

RLAY
4,625
0,005 (0,11%)
Ultimo aggiornamento: 16:34:38
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/1/202522:05GLOBERelay Therapeutics to Present at 43rd Annual J.P. Morgan..
07/1/202502:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:05EDGAR2Form 144 - Report of proposed sale of securities
31/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:01EDGAR2Form 144 - Report of proposed sale of securities
18/12/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:18EDGAR2Form 144 - Report of proposed sale of securities
11/12/202413:00EDGAR2Form 8-K - Current report
11/12/202412:00GLOBERelay Therapeutics Announces Updated Interim Data for..
09/12/202422:05GLOBERelay Therapeutics to Present Updated Clinical Data on..
03/12/202414:01GLOBEElevar Therapeutics and Relay Therapeutics Announce..
03/12/202414:00GLOBERelay Therapeutics and Elevar Therapeutics Announce..
07/11/202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
06/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:10EDGAR2Form 8-K - Current report
06/11/202422:05GLOBERelay Therapeutics Reports Third Quarter 2024 Financial..
30/10/202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:05GLOBERelay Therapeutics to Announce Third Quarter 2024 Financial..
29/10/202421:04EDGAR2Form 144 - Report of proposed sale of securities
28/10/202421:05EDGAR2Form 144 - Report of proposed sale of securities
01/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:27EDGAR2Form 144 - Report of proposed sale of securities
11/9/202422:49EDGAR2Form 8-K - Current report
11/9/202422:45EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202402:21GLOBERelay Therapeutics Announces Pricing of Public Offering of..
09/9/202422:43EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/9/202422:34GLOBERelay Therapeutics Announces Proposed Public Offering of..
09/9/202414:00EDGAR2Form 8-K - Current report
09/9/202412:55GLOBERelay Therapeutics Announces Positive Interim Data for..
06/9/202422:05GLOBERelay Therapeutics Announces Webcast to Report RLY-2608 Data..
06/8/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
06/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:10EDGAR2Form 8-K - Current report
06/8/202422:05GLOBERelay Therapeutics Reports Second Quarter 2024 Financial..
01/8/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202400:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:06EDGAR2Form 144 - Report of proposed sale of securities
30/7/202422:19EDGAR2Form 144 - Report of proposed sale of securities
30/7/202422:05GLOBERelay Therapeutics to Announce Second Quarter 2024 Financial..
30/7/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/7/202422:29EDGAR2Form 144 - Report of proposed sale of securities
29/7/202422:24EDGAR2Form 144 - Report of proposed sale of securities
26/7/202422:47EDGAR2Form 144 - Report of proposed sale of securities
25/7/202422:05EDGAR2Form 144 - Report of proposed sale of securities
16/7/202422:15EDGAR2Form 8-K - Current report
12/6/202422:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202414:00EDGAR2Form 8-K - Current report
Apertura: 4,57 Min: 4,52 Max: 4,67
Chiusura: 4,62

La tua Cronologia

NASDAQ
RLAY
Relay Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network